Skip to main content

Advertisement

Log in

Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations

  • Published:
Familial Cancer Aims and scope Submit manuscript

Abstract

Little of the research involving individuals undergoing testing for BRCA1/2 mutations has examined the effect of genetic counseling and testing on diet, exercise, and vitamin use. This study examined diet, exercise, and vitamin use among 120 Ashkenazi Jewish individuals with a personal and/or family history of breast and/or ovarian cancer who presented for BRCA1/2 genetic counseling and testing. Health behaviors were measured at pre-counseling and 6 months post-results. T-tests or ANOVAs were used to test for association of health behaviors with potential predictors: personal cancer history, anxiety, perceived cancer risk, gene status, and perceived efficacy of health behaviors. Multivariable linear regression analysis found gender (P = .007) and perceived efficacy of a healthy diet (P = .005) to be significantly associated with healthy food consumption; gender (P = .003), education (P = .01), and personal cancer history (P = .02) were significantly associated with unhealthy food consumption; higher age (P < .001) and perceived efficacy (P < .001) were significantly associated with higher vitamin use. Paired t-tests found no significant changes in diet, vitamin use, and exercise as a result of genetic counseling and testing. We conclude that genetic counseling and testing had little impact on health behaviors. Rather, perceived efficacies of certain health behaviors to prevent or delay cancer may be more reliable predictors of those behaviors. Clinicians should assess perceived efficacies of health behaviors in their interventions to improve healthy practices in the BRCA1/2 genetic testing population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

DQI-R:

Diet quality index-revised

CHEI:

Canadian healthy eating index

CAM:

Complementary and alternative medicine

References

  1. Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130. doi:10.1086/375033

    Article  PubMed  CAS  Google Scholar 

  2. Easton DF, Steele L, Fields P et al (1997) Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 61:120-128

    Article  PubMed  CAS  Google Scholar 

  3. d’Agincourt-Canning L (2006) A gift or a yoke? Women’s and men’s responses to genetic risk information from BRCA1 and BRCA2 testing. Clin Genet 70:462–472. doi:10.1111/j.1399-0004.2006.00720.x

    Article  PubMed  Google Scholar 

  4. Leventhal H, Diefenbach MA, Leventhal EA (1992) Illness cognition: using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 16:143–163. doi:10.1007/BF01173486

    Article  Google Scholar 

  5. Chajes V, Thiebaut AC, Rotival M et al (2008) Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC study. Am J Epidemiol 167:1312–1320. doi:10.1093/aje/kwn069

    Article  PubMed  Google Scholar 

  6. Willett WC (1999) Dietary fat and breast cancer. Toxicol Sci 52:127–146

    PubMed  CAS  Google Scholar 

  7. Howe GR (1994) Dietary fat and breast cancer risks. An epidemiologic perspective. Cancer 74:1078–1084. doi:10.1002/1097-0142(19940801)74:3<1078::AID-CNCR2820741516>3.0.CO;2-H

    Google Scholar 

  8. Willett WC, Hunter DJ, Stampfer MJ et al (1992) Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA 268:2037–2044. doi:10.1001/jama.268.15.2037

    Article  PubMed  CAS  Google Scholar 

  9. Philips R, Snowdon D (1983) Association of meat and coffee use with cancers of the large bowel, breast, and prostate among seventh-day adventists: preliminary results. Cancer Res 43:2403–2408

    Google Scholar 

  10. Toniolo P, Riboli E, Shore RE et al (1994) Consumption of meat, animal products, protein, and fat and risk of breast cancer: a prospective cohort study in New York. Epidemiology 5:391–397

    Article  PubMed  CAS  Google Scholar 

  11. Hirayama T (1985) A large scale cohort study on cancer risks by diet—with special reference to the risk reducing effects of green–yellow vegetable consumption. Princess Takamatsu Symp 16:41–53

    PubMed  CAS  Google Scholar 

  12. Gandini S, Merzenich H, Robertson C et al (2000) Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur J Cancer 36:636–646. doi:10.1016/S0959-8049(00)00022-8

    Article  PubMed  CAS  Google Scholar 

  13. Nkondjock A, Ghadirian P (2007) Diet quality and BRCA-associated breast cancer risk. Breast Cancer Res Treat 103:361–369. doi:10.1007/s10549-006-9371-0

    Article  PubMed  CAS  Google Scholar 

  14. McGuire V, John E, Felberg A et al (2006) No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer Epidemiol Biomarkers Prev 15:1565–1567. doi:10.1158/1055-9965.EPI-06-0323

    Article  PubMed  CAS  Google Scholar 

  15. Nkondjock A, Robidoux A, Paredes Y et al (2006) Diet, lifestyle and BRCA-related breast cancer risk among French–Canadians. Breast Cancer Res Treat 98:285–294. doi:10.1007/s10549-006-9161-8

    Article  PubMed  CAS  Google Scholar 

  16. Brunet JS, Ghadirian P, Rebbeck TR et al (1998) Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. J Natl Cancer Inst 90:761–766. doi:10.1093/jnci/90.10.761

    Article  PubMed  CAS  Google Scholar 

  17. Bowen DJ, Alfano CM, McGregor BA et al (2004) The relationship between perceived risk, affect, and health behaviors. Cancer Detect Prev 28:409–417. doi:10.1016/j.cdp.2004.08.008

    Article  PubMed  Google Scholar 

  18. Lemon SC, Zapka JG, Clemow L (2004) Health behavior change among women with recent familial diagnosis of breast cancer. Prev Med 39:253–262. doi:10.1016/j.ypmed.2004.03.039

    Article  PubMed  Google Scholar 

  19. Cho E, Spiegelman D, Hunter DJ et al (2003) Premenopausal intakes of vitamins A, C, and E, folate, and carotenoids, and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12:713–720

    PubMed  CAS  Google Scholar 

  20. Zhang SM (2004) Role of vitamins in the risk, prevention, and treatment of breast cancer. Curr Opin Obstet Gynecol 16:19–25. doi:10.1097/00001703-200402000-00005

    Article  PubMed  CAS  Google Scholar 

  21. Abbas S, Linseisen J, Slanger T et al (2008) Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer—results of a large case-control study. Carcinogenesis 29:93–99. doi:10.1093/carcin/bgm240

    Article  PubMed  CAS  Google Scholar 

  22. Ishitani K, Lin J, Manson JE et al (2008) A prospective study of multivitamin supplement use and risk of breast cancer. Am J Epidemiol 167(10):1197–1206. doi:10.1093/aje/kwn027

    Article  PubMed  Google Scholar 

  23. Kotsopoulos J, Narod SA (2005) Towards a dietary prevention of hereditary breast cancer. Cancer Causes Control 16:125–138. doi:10.1007/s10552-004-2593-8

    Article  PubMed  Google Scholar 

  24. Matthews AK, Sellergren SA, Huo D et al (2007) Complementary and alternative medicine use among breast cancer survivors. J Altern Complement Med 13:555–562. doi:10.1089/acm.2007.03-9040

    Article  PubMed  Google Scholar 

  25. Helyer LK, Chin S, Chui BK et al (2006) The use of complementary and alternative medicines among patients with locally advanced breast cancer—a descriptive study. BMC Cancer 6:39. doi:10.1186/1471-2407-6-39

    Article  PubMed  Google Scholar 

  26. Rakovitch E, Pignol JP, Chartier C et al (2005) Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death. Breast Cancer Res Treat 90:139–148. doi:10.1007/s10549-004-3779-1

    Article  PubMed  Google Scholar 

  27. Alamian A, Rouleau I, Simard J et al (2006) Use of dietary supplements among women at high risk of hereditary breast and ovarian cancer (HBOC) tested for cancer susceptibility. Nutr Cancer 54:157–165. doi:10.1207/s15327914nc5402_1

    Article  PubMed  CAS  Google Scholar 

  28. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302:643–646. doi:10.1126/science.1088759

    Article  PubMed  CAS  Google Scholar 

  29. Audrain J, Schwartz M, Herrera J et al (2001) Physical activity in first-degree relatives of breast cancer patients. J Behav Med 24:587–603. doi:10.1023/A:1012943411367

    Article  PubMed  CAS  Google Scholar 

  30. Rabin C, Pinto B (2006) Cancer-related beliefs and health behavior change among breast cancer survivors and their first-degree relatives. Psychooncology 15:701–712. doi:10.1002/pon.1000

    Article  PubMed  Google Scholar 

  31. Spector D (2007) Lifestyle behaviors in women with a BRCA1 or BRCA2 genetic mutation: an exploratory study guided by concepts derived from the health belief model. Cancer Nurs 30:1–10. doi:10.1097/00002820-200701000-00015

    Article  Google Scholar 

  32. Digianni L, Rue M, Emmons KM et al (2006) Complementary medicine use before and 1 year following genetic testing for BRCA 1/2 mutations. Cancer Epidemiol Biomarkers Prev 15:70–75. doi:10.1158/1055-9965.EPI-05-0646

    Article  PubMed  Google Scholar 

  33. Roa BB, Boyd AA, Volcik K et al (1996) Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 14:185–187. doi:10.1038/ng1096-185

    Article  PubMed  CAS  Google Scholar 

  34. Kelly K, Leventhal H, Marvin M et al (2004) Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations. Genet Test 8:139–147

    PubMed  CAS  Google Scholar 

  35. Kelly K, Leventhal H, Andrykowski M et al (2005) Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psychooncology 14:34–48. doi:10.1002/pon.805

    Article  PubMed  Google Scholar 

  36. Trepanier A, Ahrens M, McKinnon W et al (2004) Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. J Genet Couns 13:83–114. doi:10.1023/B:JOGC.0000018821.48330.77

    Article  PubMed  Google Scholar 

  37. Tonin P, Weber B, Offit K et al (1996) Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2:1179–1183. doi:10.1038/nm1196-1179

    Article  PubMed  CAS  Google Scholar 

  38. Kelly K, Leventhal H, Andrykowski M et al (2004) The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations. J Genet Couns 13:237–257. doi:10.1023/B:JOGC.0000027959.37096.78

    Article  PubMed  Google Scholar 

  39. McNair D, Lorr M, Droppleman L (1971) Profile of mood states. Educational and Industrial Testing Service, San Diego, CA

    Google Scholar 

  40. Lerman C, Trock B, Rimer BK et al (1991) Psychological side effects of breast cancer screening. Health Psychol 10:259–267. doi:10.1037/0278-6133.10.4.259

    Article  PubMed  CAS  Google Scholar 

  41. Lerman C, Kash K, Stefanek M (1994) Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. J Natl Cancer Inst Monogr 16:171–176

    PubMed  Google Scholar 

  42. Benyamini Y, Idler EL, Leventhal H et al (2000) Positive affect and function as influences on self-assessments of health: expanding our view beyond illness and disability. J Gerontol 55B:107–116

    Google Scholar 

  43. Lindsey AM, Waltman N, Gross G et al (2004) Cancer risk-reduction behaviors of breast cancer survivors. West J Nurs Res 26:872–890. doi:10.1177/0193945903261274

    Article  PubMed  Google Scholar 

  44. McBride CM, Clipp E, Peterson BL et al (2000) Psychological impact of diagnosis and risk reduction among cancer survivors. Psychooncology 9:418–427. doi:10.1002/1099-1611(200009/10)9:55<418::AID-PON474>3.0.CO;2-E

    Google Scholar 

Download references

Acknowledgments

Funding was provided by the Mid-Atlantic Regional Human Genetics Network (MARHGN), New Jersey Commission on Cancer Research (NJCCR), the National Cancer Institute (R03 CA128459-01) and the Roessler Research Scholarship Fund.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kimberly M. Kelly.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quach, J., Porter, K., Leventhal, H. et al. Health behaviors among Ashkenazi Jewish individuals receiving counseling for BRCA1 and BRCA2 mutations. Familial Cancer 8, 241–250 (2009). https://doi.org/10.1007/s10689-009-9235-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10689-009-9235-y

Keywords

Navigation